Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:HCWB
日付受信時刻ニュースソース見出しコード企業名
2025/02/1206 : 54Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:HCWBHCW Biologics Inc
2025/02/0806 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2025/02/0321 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2025/02/0321 : 15GlobeNewswire Inc.HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical TrialNASDAQ:HCWBHCW Biologics Inc
2025/01/1521 : 00GlobeNewswire Inc.HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025NASDAQ:HCWBHCW Biologics Inc
2024/12/2322 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/12/2322 : 10GlobeNewswire Inc.HCW Biologics Inc. Received NASDAQ Staff Determination LetterNASDAQ:HCWBHCW Biologics Inc
2024/12/0606 : 37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:HCWBHCW Biologics Inc
2024/11/2306 : 53Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:HCWBHCW Biologics Inc
2024/11/2306 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/11/2106 : 42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/11/2102 : 54Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:HCWBHCW Biologics Inc
2024/11/1911 : 27GlobeNewswire Inc.HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNASDAQ:HCWBHCW Biologics Inc
2024/11/1821 : 00GlobeNewswire Inc.HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNASDAQ:HCWBHCW Biologics Inc
2024/11/1821 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/11/1507 : 14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
2024/11/1507 : 13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/11/1506 : 40GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
2024/09/2106 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/08/2405 : 35Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HCWBHCW Biologics Inc
2024/08/2405 : 30GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionNASDAQ:HCWBHCW Biologics Inc
2024/08/1505 : 45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
2024/08/1505 : 40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/08/1505 : 35GlobeNewswire Inc.HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:HCWBHCW Biologics Inc
2024/08/1305 : 35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/07/1820 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/06/1805 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HCWBHCW Biologics Inc
2024/06/1805 : 33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HCWBHCW Biologics Inc
2024/05/2105 : 36Edgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:HCWBHCW Biologics Inc
2024/05/1606 : 21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HCWBHCW Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:HCWB